FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4238173849> ?p ?o ?g. }

• W4238173849 abstract "Of the many psychiatric symptoms that may result from brain injury, agitation and/or aggression are often the most troublesome. It is therefore important to evaluate the efficacy of psychotropic medication used in its management.To evaluate the effects of drugs for agitation and/or aggression following acquired brain injury (ABI).We searched MEDLINE (1966-2002), EMBASE (1980-2002) and the Cochrane Controlled Trials Register (1996-2002), Web of Science Citation Index, reference lists of papers meeting the inclusion criteria and recent reviews. We handsearched Brain Injury and the Journal of Head Trauma Rehabilitation. There were no language restrictions.Randomised controlled trials (RCTs) that evaluated the efficacy of drugs acting on the central nervous system for agitation and/or aggression, secondary to ABI, in participants over 10 years of age. Studies using lower levels of evidence (i.e. case series studies, single case studies and controlled group comparison studies), were collated in an appendix.Two reviewers independently extracted data and assessed trial quality. Authors were contacted where necessary for additional information. Studies of patients within six months after brain injury and/or in a confusional state, were distinguished from those of patients more than six months post-injury, or who were not confused.Six randomised controlled trials were identified. Four RCTs evaluated the beta-blockers, propranolol and pindolol, one RCT evaluated the central nervous system stimulant, methylphenidate and one RCT evaluated amantadine, a drug normally used in parkinsonism and related disorders. The best evidence of effectiveness in the management of agitation and/or aggression following ABI was for beta-blockers. Two RCTs found propranolol to be effective (one study early and one late after injury). However, these studies used relatively small numbers, have not been replicated, used large doses, and did not use a global outcome measure or long-term follow-up. Comparing early agitation to late aggression, there was no evidence for a differential drug response. Firm evidence that carbamazepine or valproate is effective in the management of agitation and/or aggression following ABI is lacking.Numerous drugs have been tried in the management of aggression in ABI but without firm evidence of their efficacy. It is therefore important to choose drugs with few side effects and to monitor their effect. Beta-blockers have the best evidence for efficacy and deserve more attention. The lack of evidence highlights the need for better evaluations of drugs for this important problem." @default.
• W4238173849 created "2022-05-12" @default.
• W4238173849 creator A5071671204 @default.
• W4238173849 creator A5078791685 @default.
• W4238173849 creator A5090047720 @default.
• W4238173849 date "2003-01-20" @default.
• W4238173849 modified "2023-09-27" @default.
• W4238173849 title "Pharmacological management for agitation and aggression in people with acquired brain injury" @default.
• W4238173849 cites W109795170 @default.
• W4238173849 cites W112352086 @default.
• W4238173849 cites W121136978 @default.
• W4238173849 cites W1630519539 @default.
• W4238173849 cites W169289805 @default.
• W4238173849 cites W1758155888 @default.
• W4238173849 cites W182725121 @default.
• W4238173849 cites W1967716932 @default.
• W4238173849 cites W1969271590 @default.
• W4238173849 cites W1969580646 @default.
• W4238173849 cites W1971471916 @default.
• W4238173849 cites W1971789030 @default.
• W4238173849 cites W1972161141 @default.
• W4238173849 cites W1978733745 @default.
• W4238173849 cites W1986215651 @default.
• W4238173849 cites W1987127523 @default.
• W4238173849 cites W1988931044 @default.
• W4238173849 cites W1995876262 @default.
• W4238173849 cites W1997708148 @default.
• W4238173849 cites W1998748704 @default.
• W4238173849 cites W2000725783 @default.
• W4238173849 cites W2002501515 @default.
• W4238173849 cites W2003266511 @default.
• W4238173849 cites W2021655452 @default.
• W4238173849 cites W2032256476 @default.
• W4238173849 cites W2032991755 @default.
• W4238173849 cites W2033812365 @default.
• W4238173849 cites W2042244803 @default.
• W4238173849 cites W2044443383 @default.
• W4238173849 cites W2048473588 @default.
• W4238173849 cites W2052262163 @default.
• W4238173849 cites W2052621814 @default.
• W4238173849 cites W2055039185 @default.
• W4238173849 cites W2058959684 @default.
• W4238173849 cites W2064839408 @default.
• W4238173849 cites W2065172102 @default.
• W4238173849 cites W2067791685 @default.
• W4238173849 cites W2071113624 @default.
• W4238173849 cites W2072897782 @default.
• W4238173849 cites W2076446720 @default.
• W4238173849 cites W2077388796 @default.
• W4238173849 cites W2079323119 @default.
• W4238173849 cites W2080816111 @default.
• W4238173849 cites W2082873275 @default.
• W4238173849 cites W2083612258 @default.
• W4238173849 cites W2090989307 @default.
• W4238173849 cites W2091165711 @default.
• W4238173849 cites W2103906457 @default.
• W4238173849 cites W2108140351 @default.
• W4238173849 cites W2113465450 @default.
• W4238173849 cites W2114224394 @default.
• W4238173849 cites W2117134295 @default.
• W4238173849 cites W2130281953 @default.
• W4238173849 cites W2130323362 @default.
• W4238173849 cites W2135181116 @default.
• W4238173849 cites W2140648495 @default.
• W4238173849 cites W2140873297 @default.
• W4238173849 cites W2148499303 @default.
• W4238173849 cites W2153875514 @default.
• W4238173849 cites W2159210845 @default.
• W4238173849 cites W2164055530 @default.
• W4238173849 cites W2164346310 @default.
• W4238173849 cites W2165740328 @default.
• W4238173849 cites W2171026237 @default.
• W4238173849 cites W2171917610 @default.
• W4238173849 cites W2172214328 @default.
• W4238173849 cites W2314352173 @default.
• W4238173849 cites W2405398183 @default.
• W4238173849 cites W2410447563 @default.
• W4238173849 cites W2414453576 @default.
• W4238173849 cites W2415557736 @default.
• W4238173849 cites W2466339889 @default.
• W4238173849 cites W4238282830 @default.
• W4238173849 cites W4248000597 @default.
• W4238173849 cites W4250409052 @default.
• W4238173849 cites W4252608859 @default.
• W4238173849 cites W4300758294 @default.
• W4238173849 cites W45032874 @default.
• W4238173849 doi "https://doi.org/10.1002/14651858.cd003299" @default.
• W4238173849 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12535468" @default.
• W4238173849 hasPublicationYear "2003" @default.
• W4238173849 type Work @default.
• W4238173849 citedByCount "17" @default.
• W4238173849 countsByYear W42381738492012 @default.
• W4238173849 countsByYear W42381738492016 @default.
• W4238173849 countsByYear W42381738492017 @default.
• W4238173849 countsByYear W42381738492018 @default.
• W4238173849 countsByYear W42381738492021 @default.
• W4238173849 countsByYear W42381738492022 @default.
• W4238173849 countsByYear W42381738492023 @default.
• W4238173849 crossrefType "reference-entry" @default.
• W4238173849 hasAuthorship W4238173849A5071671204 @default.

• next